11
Feb

Biopharma’s M&A rate jumped 11% in 2013 with the average deal value soaring 46%, according to PricewaterhouseCoopers, and analysts expect that healthy flow to continue into the new year.

…read more

Source: Report: Last year’s dealmaking boom will roll on into 2014

    

0 No comments